GRIFOLS | GRF - Selling And Administration Expenses



GRIFOLS reported EUR282.76M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Alcon AG USD 870M 57M Jun/2025
Almirall EUR 91.3M 55.52M Mar/2025
Amadeus IT EUR 497.5M 206.6M Mar/2025
Amarin USD 36.57M 397K Mar/2025
argenx SE USD 321.35M 45.11M Jun/2025
AstraZeneca USD 5.01B 1.42B Jun/2025
Bayer EUR 3.55B 162M Jun/2025
Cie Automotive EUR 315.66M 28.06M Dec/2024
Demant DKK 5.95B 319M Jun/2025
Ence Energia y Celulosa EUR 29.1M 2M Sep/2024
Essilor EUR 1.09B 2.08B Jun/2025
Ferrovial EUR 906M 52M Dec/2024
Fresenius EUR 740M 97M Jun/2025
Fresenius Medical Care EUR 792M 41M Jun/2025
Galapagos EUR 30.67M 13.12M Jun/2025
Genmab DKK 144M 18M Jun/2025
GlaxoSmithKline GBP 2.14B 80M Jun/2025
GRIFOLS EUR 282.76M 41.9M Jun/2025
Hikma Pharmaceutical USD 288M 8M Dec/2024
Inditex 2.51B 7.98B Jan/2025
Merck EUR 1.48B 9M Jun/2025
Novartis USD 3.44B 384M Jun/2025
Philips EUR 1.24B 9M Jun/2025
Roche Holding CHF 3.61B 381M Dec/2024
Sanofi EUR 2.63B 408M Jun/2025
Smith & Nephew USD 1.42B 77.8M Jun/2025
UCB EUR 1.29B 221M Dec/2024
Viscofan 68.07M 61.17M Sep/2024